Showing results (11-20 of 110) with videos related to
Sort By:
Pageof 11
Gene Therapy|November 8, 2021
Endotoxin contamination in commercially available Cas9 proteins potentially induces T-cell mediated responsesVijaya L Simhadri, Joseph R McGill, Zuben E SaunaEuropean Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 15, 2005
The power of the pump: mechanisms of action of P-glycoprotein (ABCB1)Suresh V Ambudkar, In-Wha Kim, Zuben E SaunaInternational Journal of Molecular Sciences|May 24, 2020
Role of microRNAs in Hemophilia and Thrombosis in HumansKatarzyna I Jankowska, Zuben E Sauna, Chintamani D AtreyaJournal of Thrombosis and Haemostasis : JTH|May 8, 2024
Application of machine learning approaches for predicting hemophilia A severityAtul Rawal, Christopher Kidchob, Jiayi Ou, et al.Trends in Molecular Medicine|September 8, 2021
Secondary failure: immune responses to approved protein therapeuticsH A Daniel Lagassé, Quinn McCormick, Zuben E SaunaFrontiers in Medicine|May 24, 2021
HLA Variants and Inhibitor Development in Hemophilia A: A Retrospective Case-Controlled Study Using the ATHNdatasetJoseph R McGill, Vijaya L Simhadri, Zuben E SaunaFrontiers in Immunology|May 30, 2023
Understanding preclinical and clinical immunogenicity risks in novel biotherapeutics developmentZuben E Sauna, Vibha Jawa, Sathy Balu-Iyer, et al.Hearing Research|June 7, 2015
The tip-link molecular complex of the auditory mechano-electrical transduction machineryElise Pepermans, Christine PetitTrends in Biotechnology|December 10, 2014
Fc fusion as a platform technology: potential for modulating immunogenicityDitza Levin, Basil Golding, Scott E Strome, et al.Trends in Pharmacological Sciences|October 30, 2023
Emerging approaches to induce immune tolerance to therapeutic proteinsJustine C Noel, Daniel Lagassé, Basil Golding, et al.Pageof 11